Urate

Biomarker4 papers1 finding

  • Human trial1
  • Humans2
  • Model organisms1

Interventions

1

Dapagliflozin

downin humans1Moderate certainty

1 study
  1. Dapagliflozin decreases urate in humans (P-interaction < 0.001).

    Human trialPAH or CTEPH on background vasodilator therapyserum10 mg daily12 weeksn = 52

    Dapagliflozin in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: The DAPAH randomized controlled trial · The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation · 31 Aug 2026

Dapagliflozin →

Latest

Nov 2025: 1Dec 2025: 1Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 4Sep 2026: 7Oct 2026: 216
Research SquareHumansPreprint

Uric acid salt linked to high-risk plaque in heart arteries

In an observational study of 116 patients, detected urate was linked to odds of high-risk plaque 4.91 times those without detected urate.In an observational study of 116 patients, detected urate was linked to odds of high-risk plaque 4.91 times those without detected urate.